<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>医药云端工作室 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-20T20:25:42+08:00</updated>
  <subtitle>医药行业领先的智库，连接政策与市场的桥梁</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>江苏集采来了，纳入品种或将少于30个；陕西联盟或有15个纳入</title>
    <updated>2020-11-20T18:35:33+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/ON_Cram-54sEWlPwkYHJ7A</id>
    <link href="https://mp.weixin.qq.com/s/ON_Cram-54sEWlPwkYHJ7A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>正式公布：医药价格和招采信用评价细则出台！商业贿赂、涉税、价格违法......</title>
    <updated>2020-11-20T18:35:33+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/xYPQVqj9_ubyJQtGppFclA</id>
    <link href="https://mp.weixin.qq.com/s/xYPQVqj9_ubyJQtGppFclA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>刚刚！DIP技术规范和目录库公布了！DRG和DIP将带来哪些影响？如何应对？</title>
    <updated>2020-11-20T18:35:33+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/AplZcRuNZ9poJ8yURCyoeA</id>
    <link href="https://mp.weixin.qq.com/s/AplZcRuNZ9poJ8yURCyoeA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CDE发文，两类情形可申请附条件批准上市</title>
    <updated>2020-11-20T18:35:33+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/XqvPlesdVAQ4O_GgGT94Rw</id>
    <link href="https://mp.weixin.qq.com/s/XqvPlesdVAQ4O_GgGT94Rw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>37幅图、27张表格，全景研究药品、耗材采购政策</title>
    <updated>2020-11-19T19:05:25+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/xfhMYI6a46x3t8516gWeUQ</id>
    <link href="https://mp.weixin.qq.com/s/xfhMYI6a46x3t8516gWeUQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>广东、福建、重庆药价不再是“禁区，河北马上采集”</title>
    <updated>2020-11-19T19:05:25+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/Jy9B-i1BuViA-OfDyJeJBA</id>
    <link href="https://mp.weixin.qq.com/s/Jy9B-i1BuViA-OfDyJeJBA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>注意！7种医院制剂不纳入医保支付范围</title>
    <updated>2020-11-19T19:05:25+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/jL17byJsMOzZUXDnZ8RGEg</id>
    <link href="https://mp.weixin.qq.com/s/jL17byJsMOzZUXDnZ8RGEg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>又一连锁药店上市，“药店五福”集齐了！</title>
    <updated>2020-11-19T19:05:25+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/8ulHQNP6EGUTShYu6nKOZQ</id>
    <link href="https://mp.weixin.qq.com/s/8ulHQNP6EGUTShYu6nKOZQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>基药目录调整的五大方向流出，药企提出6条建议</title>
    <updated>2020-11-18T18:28:47+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/8dQlnj0J5dZ2Q5VyqZKkjA</id>
    <link href="https://mp.weixin.qq.com/s/8dQlnj0J5dZ2Q5VyqZKkjA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医保待遇统一标准将出，国家医保局明确这些项目不报销</title>
    <updated>2020-11-18T18:28:47+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/2E1vEn8wDMZ1v1cVBdB3wA</id>
    <link href="https://mp.weixin.qq.com/s/2E1vEn8wDMZ1v1cVBdB3wA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【一致性评价持续更新90周】7款注射剂通过补充申请通过一致性评价</title>
    <updated>2020-11-18T18:28:47+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/9jI0-HptyqRWylxakrjJiQ</id>
    <link href="https://mp.weixin.qq.com/s/9jI0-HptyqRWylxakrjJiQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>即将恢复原价！《中国药品采购政策研究报告2020》</title>
    <updated>2020-11-18T18:28:47+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/wUgvtPxbmM1RjgGG6Ej4fA</id>
    <link href="https://mp.weixin.qq.com/s/wUgvtPxbmM1RjgGG6Ej4fA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>打通市场准入的任督二脉，最新版药品采购研报发布</title>
    <updated>2020-11-17T21:01:41+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/11Z1n2rxWJEdyP-4caenBA</id>
    <link href="https://mp.weixin.qq.com/s/11Z1n2rxWJEdyP-4caenBA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>9个参比制剂未通过审议，另有27个新增，15个增补（附名单）</title>
    <updated>2020-11-17T21:01:41+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/u-zGnTijiTJl6CodUg0xxQ</id>
    <link href="https://mp.weixin.qq.com/s/u-zGnTijiTJl6CodUg0xxQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>江西非中选药品将联动联采办梯度降价</title>
    <updated>2020-11-17T21:01:41+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/w-HmmZVbQ6eLdaiBicjS7w</id>
    <link href="https://mp.weixin.qq.com/s/w-HmmZVbQ6eLdaiBicjS7w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>预售倒计时！《中国药品采购政策研究报告2020》即将恢复原价</title>
    <updated>2020-11-17T21:01:41+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/BlpWwiKXxadpa23eJ0gRFA</id>
    <link href="https://mp.weixin.qq.com/s/BlpWwiKXxadpa23eJ0gRFA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>基药目录管理办法出台在即，四川邀12家药企调研</title>
    <updated>2020-11-16T21:57:46+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/PE-WufkDETc1tsy39u0k1Q</id>
    <link href="https://mp.weixin.qq.com/s/PE-WufkDETc1tsy39u0k1Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>人也杀了，价也降了，然后呢？从价格双轨制，推演公立的衰落，新王当立</title>
    <updated>2020-11-16T21:57:46+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/8H_FiyNAYc6YiuCGI5jNKw</id>
    <link href="https://mp.weixin.qq.com/s/8H_FiyNAYc6YiuCGI5jNKw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>158个药品新增挂网（附名单）</title>
    <updated>2020-11-16T21:57:46+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/96QoeOYQ7biJ9vSL29jIFA</id>
    <link href="https://mp.weixin.qq.com/s/96QoeOYQ7biJ9vSL29jIFA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>11.28-29 广州《带量采购+新医保支付下的耗材企业应对实务》</title>
    <updated>2020-11-16T21:57:46+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/6r-pUYuSy6Uao3wilizW6Q</id>
    <link href="https://mp.weixin.qq.com/s/6r-pUYuSy6Uao3wilizW6Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>